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Comment
The Schiff base ligands derived from 1-amino-4-methylpiperazine have attracted the interest due to diverse biological applications found with piperazine moiety. Schiff base piperazine derivatives were found to be designed for the study of their antimicrobial activity (Savaliya et al., 2010) and antibacterial activity (Xu et al., 2012) . A valuable insight into recent advances on antimicrobial activity of piperazine derivatives is reported (Kharb et al., 2012) . A review on the current pharmacological and toxicological information for piperazine derivatives is described (Elliott, 2011) . The crystal structures of some related compounds, viz., 2-[(4-methylpiperazin-1-yl)iminomethyl]phenol (Guo, 2007) , 1,4-bis- (Xu et al., 2009 ), 2-methoxy-4-[(4-methylpiperazin-1-yl)iminomethyl]phenol (Zhou et al., 2011) and 2,4-dibromo-6-[(4-methylpiperazin-1-yl) iminomethyl]phenol (Guo & Qiu, 2007) have been reported. The crystal structures of similar Schiff bases, viz, (1H-indol-3-yl-methylene)-(4-methylpiperazin-1-yl)-amine (Kavitha et al., 2013a) and (4-methyl-piperazin-1-yl)-(2-nitro-benzylidene)-amine (Kavitha et al., 2013b ) have been reported. The title compound is a Schiff base prepared by the reaction of 1-amino-4-methylpiperazine and 2,3,4-trimethoxy benzaldehyde. In view of the above importance of N-piperazinyl Schiff bases, the title compound, (I), C 15 H 23 N 3 O 3 , has been synthesized and the crystal structure is reported.
The title compound, (I), crystallizes with one independent molecule in the asymmetric unit. In the molecule, the piperazine ring is in a slightly disordered chair conformation (puckering parameters Q, θ, and φ = 0.5691 (15)Å, 176.10 (14)° and 160 (2)°, respectively; (Cremer & Pople, 1975) and is twisted from the mean plane of the phenyl ring with a N2/N3/C5/C6 torsion angle of 177.3 (7)° (Fig. 1) . The 4-methoxy substituent with a C10/C9/O3/C15 torsion angle of 5.4 (1)° is almost planar with respect to the mean plane of the phenyl ring while the methoxy groups at positions 2 and 3, with torsion angles of 122.6 (4)° (C6/C7/O1/C13) and -66.1 (4)° (C9/C8/O2/C14), are twisted away from the mean plane of the phenyl ring in anti-clinical and -syn-clinical conformations, respectively. Bond lengths are in normal ranges (Allen et al., 1987) . No classical hydrogen bonds or any weak intermolecular interactions are observed.
Experimental
To a solution of 2,3,4-trimethoxy benzaldehyde (0.98 g, 0.005 mol) in 5 ml of methanol an equimolar amount of (1amino-4-methyl)piperazine (0.57 g, 0.005 mol) is added dropwise with constant stirring. The mixture was refluxed for eight hours . The solution was evaporated at room temperature to obtain the solid. The solid was then recrystallized using ethylacetate and the crystals were used as such for x-ray diffraction studies (m.p.: 365-369 K).
Refinement
All of the H atoms were placed in their calculated positions and then refined using the riding model with Atom-H lengths of 0.93Å (CH), 0.97Å (CH 2 ) OR 0.96Å (CH 3 ). Isotropic displacement parameters for these atoms were set to 1.2 (CH, CH 2 ) or 1.5 (CH 3 ) times U eq of the parent atom. Idealised Me refined as rotating groups. Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq O1 0.29270 (12) 0.40317 (7) 0.0374 (7) 0.0333 (7) 0.0366 (7) 0.0029 (5) −0.0056 (5) −0.0002 (5) C2 0.0347 (6) 0.0356 (7) 0.0355 (6) 0.0017 (5) −0.0098 (5) −0.0020 (5) C3 0.0395 (7) 0.0360 (7) 0.0298 (6) −0.0035 (5) −0.0063 (5) 0.0019 (5) C4 0.0438 (7) 0.0399 (7) 0.0278 (6) −0.0075 (6) −0.0038 (5) −0.0022 (5) 
